Pharmacy chains CVS, Walgreens and Rite Aid are all set to close stores. Here's the latest on each company.

It has been a rough stretch for large pharmacy chains. CVS, Walgreens and Rite Aid are all in the midst of mass closures, and Rite Aid recently filed for bankruptcy for the second time in as many ...

Last year, Walgreens announced its plans to close approximately 1,200 stores throughout the U.S., with around 500 closures expected to happen within the 2025 fiscal year. Walgreens operates more ...

Walgreens is closing more stores in Raleigh and Durham soon as part of the company’s response to larger business pressures.. The pharmacy giant is shutting down about 1,200 locations across the ...

Walgreens said in October 2024 it planned to close about 1,200 stores across the U.S., starting with about 500 stores in fiscal year 2025. “Fiscal 2025 will be an important rebasing year as we ...

Walgreens told CNBC it hopes to have its 11 micro-fulfillment centers serve more than 5,000 stores by the end of the year, up from 4,800 in February and 4,300 in October 2023.

Walgreens has already announced plans to close about 1,200 of its 8,500 U.S. drugstores. Related: Walgreens to close 1,200 drugstores, in 'turnaround' after $3B loss ...

A Walgreens store in New York City. Walgreens in March reached a roughly $10 billion deal with the private equity firm Sycamore Partners to go private, a move that would see it delisted from ...

Pharmacy giant Walgreens has reached a $300 million settlement with the U.S. Department of Justice over allegations it filled millions of invalid opioid and other drug prescriptions during the ...

Walgreens will pay up to $350 million in a settlement to resolve claims that the company filled invalid prescriptions for opioids. Many of these invalid prescriptions were paid for by Medicare.

National pharmaceutical retailer Walgreens has agreed to pay at least $300 million to settle allegations it illegally fulfilled millions of invalid controlled substance prescriptions for more than … ...

The story of Walgreens’ decline is a business case study in leadership missteps, shifting consumer behaviors and competitive pressures. But at its core, Walgreens’ fall is a marketing failure.